Join our Mission –
together against
COVID-19

Facts about SARS CoV-2 and
how to prevent infection

Nurse at Clinic Heidenheim

We help, care, protect - Mission: Infection Prevention

Q1 2023:

HARTMANN: negative impact on earnings continues in the first quarter of 2023 due to high additional material costs and reduced market demand

In the first three months of financial year 2023, the HARTMANN GROUP generated sales revenues of EUR 583.5 million. This corresponds to an organic sales increase of 3.4% compared to the prior-year period. Adjusted EBITDA amounted to EUR 49.9 million, a decrease of EUR -3.6 million compared to the first quarter of 2022.

We take care of MDR so you can care better.

bg-country-switch

To those who give with their entire heart and soul – to take care of others

Our society could not function without family managers. Yet their dedication often goes unacknowledged.

Incontinence: it’s time to break the silence

Millions of people live with urinary incontinence. One in five of us aged over 40 has the condition. Yet it remains a subject we don’t seem comfortable talking about; with many suffering in silence rather than asking for the help that’s out there. Isn’t it time to break one of the last remaining taboos in health?

Helps. Cares. Protects.

For 200 years, HARTMANN has proudly channeled its clinical and medical expertise into smart solutions that are accessible to everyone. HARTMANN will continue to be a partner to healthcare institutions while strengthening its outpatient activities even more.

We: Help. Care. Protect.

It is an exciting time to work in healthcare. Healthcare faces some tough challenges such as budget cuts, ageing populations, and increases in non-communicable diseases. That means there are plenty of opportunities to shape the healthcare of the future. HARTMANN has challenged healthcare conventions for 200 years and continues to go further with product solutions for hospitals that protect surgical teams and let them and the hospital work more efficiently. HARTMANN offers wound treatments that make health economic sense and bring simplicity to patients and caregivers’ lives. HARTMANN provides discreet solutions for people with incontinence that preserve their dignity. And HARTMANN continues to pioneer disinfection solutions for healthcare professionals all over the world.

HARTMANN solutions are available in over 100 countries around the world.

News

HARTMANN: negative impact on earnings continues in the first quarter of 2023 due to high additional material costs and reduced market demand

The first quarter of 2023 saw a continuation of the sales and earnings levels of the previous two quarters as the business continued to be characterized by high additional material costs and reduced market demand. In particular, demand for disinfection products remained below pre-pandemic levels. Inflation also led to reduced purchasing power,...

Financial year 2022: Significant earnings contribution from Transformation Program dampens prevailing crisis-related burdens

HARTMANN publishes Quarterly Report 3/2022. Business developments affected by a tense economic and geopolitical situation

Rimasys and HARTMANN: A partnership for surgical excellence

HARTMANN GROUP and Rimasys Group have joined forces to support orthopedic and medical emergency professionals with the education and products they need to achieve the best possible outcomes for patients in the operating theater.

HARTMANN affected by significant cost increases

HARTMANN's business performance in the first nine months of 2022 is the result of significantly increased material, transportation and energy costs. Currency effects also had a negative impact. In addition, supply chains remained destabilized and there were risks with regard to energy supply.

Figures for the first half of 2022 particularly affected by cost increases for materials

Massive increases in costs for materials, transportation and energy significantly impacted the Company's business performance in the first half of 2022. With the outbreak of the Russian Ukrainian war, raw material prices continued to rise, which increasingly destabilized global supply chains and energy supplies.

HARTMANN and GWA Hygiene enter into strategic partnership for digital health solutions

Since the beginning of the COVID 19 pandemic at the latest, it has been known how important good hand hygiene is. The digital NosoEx® system from GWA Hygiene provides targeted support for nurses, doctors and hygienists. As part of its digital approach, HARTMANN will begin distributing the hygiene solution for healthcare facilities, thereby...

HARTMANN starts 1st quarter with lower earnings

The rising costs of materials, transportation, and energy, already on the rise since last year, significantly impacted HARTMANN's business performance in the first three months of 2022. The outbreak of the Russian-Ukrainian war exacerbated this development even further. By contrast, for the first time since its outbreak, the coronavirus...

HARTMANN announces price increase

Health care company HARTMANN is announcing price increases in most product categories and markets to compensate the significant higher costs for raw material, energy and freight that have been hitting the markets for several months.

Financial year 2021 characterized by coronavirus and progress in the Transformation Program

The 2021 financial year was again dominated by the strong impact of the coronavirus and progress with the Transformation Program. The expected decline in key financial figures is mainly due to the pandemic. The pandemic-related extraordinary demand for disinfectants and personal protective equipment subsided as our customers meanwhile had large...

HARTMANN issues earnings warning for 2022

The HARTMANN GROUP expects a moderate organic decline in sales for financial year 2022 with an adjusted EBITDA in the range of EUR 180 to 220 million, which corresponds to a decline of approximately EUR 35 million as compared to 2021.

HARTMANN invests 40 million euros in the Heidenheim region

As part of its transformation program, the HARTMANN GROUP will invest a total of approximately 40 million euros in the production site at Herbrechtingen between 2021 and 2023. 20 million will be used for a new production line and a further 20 million euros for the modernization of existing facilities and infrastructure.

Sales and earnings continue to decline

The coronavirus pandemic continued to have a significant impact on HARTMANN's business development in the third quarter of 2021. Across all business segments, the Company generated revenue of EUR 1,704.9 million in the first nine months of the 2021 financial year. This equates to a moderate organic decline in revenue of -5.6% compared to the...

HARTMANN’s sales and earnings decline compared with previous quarters, as expected

The impact of the coronavirus pandemic on the HARTMANN GROUP's business development did not significantly diminish in the first six months of financial year 2021. The positive effects resulting from the pandemic, which were clearly visible in 2020, declined considerably, in particular, the demand for disinfection products and personal...

HARTMANN becomes hygiene partner of the Allianz Arena in Munich

The HARTMANN GROUP, a leading European provider of system solutions for medical applications and care, will become the official hygiene partner of the Allianz Arena for the new 2021/2022 season. Spectators at future sporting events in the Allianz Arena will be offered even greater safety thanks to a holistic hygiene concept.

Covid-19 has an overall strong positive impact on fiscal year 2020 - declining earnings expected in 2021 with high forecast uncertainty - German/English version of press release in the link

The year 2020 was significantly affected by its transformation program and the Covid-19 pandemic. The improvement in key financial figures, with considerable organic sales growth and a strong increase in earnings, is mainly due to temporary effects of the pandemic. There is a high degree of forecast uncertainty for 2021 as the further...

Changes in the Management Board of the HARTMANN GROUP

Michel Kuehn and Dr. Raymund Heinen set to retire and Stefan Grote appointed as Board Member for Incontinence Management.

Show More

Mission Infection Prevention

As a responsibility of the HARTMANN GROUP, our new initiative intends to improve infection prevention in the medical and care sector. Learn more about Mission: Infection Prevention, what we’ve already achieved and how to contribute. Join the mission.

Read more

Press

Stay up-to-date with all the local and international news from the HARTMANN GROUP.

Read more

Our values

HARTMANN’s vision is based on a strong set of values: passion, partnership and professionalism.

Read more

HARTMANN brand

Our brand identity expresses what we stand for, what we do, and why Hartmann is unique. We took our devotion to healthcare, our dedication to customers and patients, and our passion for everything we do, and put it all into our new brand campaign look – in terms of products, services and communication channels.

Read more

Work with us

Join HARTMANN and take an active role in shaping the future of healthcare. We are looking for people who can inspire and help us Go further for health.

Discover the benefits